Assignment of Assignor's Interest

Recorded: 2023-11-14 Pages: 9

Assignor

CADENT THERAPEUTICS, INC.

Executed: 2022-12-01

Assignee

NOVARTIS AG

LICHTSTRASSE 35, BASEL, 4056, SWITZERLAND

Covered Property (1)

Heteroaromatic Nmda Receptor Modulators and Uses Thereof

Application: 18/221,694 →

Publication: US 2024/0199617

Related Assignments (1)

Other recorded transfers of the patent in this record — the chain of ownership.